EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension

Shahzad G Raja

Recent Patents on Cardiovascular Drug Discovery · 01.06.2012 · 7 (2) · 100-104

DOI: 10.2174/157489012801227238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on Cardiovascular Drug Discovery, erschienen am 01.06.2012. Verfasst von Shahzad G Raja. Beteiligte Einrichtung: Harefield Hospital, London, United Kingdom. drrajashahzad@hotmail.com. Die Arbeit wurde bisher 26-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsCardiovascular SystemDisease Models, AnimalFamilial Primary Pulmonary HypertensionHumansHypertension, PulmonaryModels, CardiovascularProtein Kinase InhibitorsSignal Transductionrho-Associated Kinases

Substanzen

Protein Kinase Inhibitors1-(5-Isoquinolinesulfonyl)-2-Methylpiperazinerho-Associated Kinasesfasudil

Autor:innen und Institutionen

  • Harefield Hospital, London, United Kingdom. drrajashahzad@hotmail.com

Zitieren

APA

Raja, S. G. (2012). Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension. Recent Patents on Cardiovascular Drug Discovery, 7(2), 100-104. https://doi.org/10.2174/157489012801227238

Vancouver

Raja SG. Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension. Recent Patents on Cardiovascular Drug Discovery. 2012;7(2):100-104. doi:10.2174/157489012801227238

BibTeX
@article{Raja2012,
  author = {Raja, Shahzad G},
  title = {Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension},
  journal = {Recent Patents on Cardiovascular Drug Discovery},
  year = {2012},
  volume = {7},
  number = {2},
  pages = {100--104},
  doi = {10.2174/157489012801227238}
}
Kostenlos starten →